GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration
Pickart L, Vasquez-Soltero JM, Margolina A. Biomed Res Int. 2015;2015:648108. View source ↗
This review synthesizes the molecular biology of GHK across multiple cellular systems relevant to dermal research. The authors describe the discovery of GHK in human plasma in 1973 at approximately 200 μg/L in young adults, declining to roughly 80 μg/L by age 60–80, and summarize the peptide's high affinity for Cu(II) which drives formation of the GHK-Cu complex in physiological conditions. Reported in vitro effects of GHK (both the free peptide and the copper complex) include modulation of extracellular matrix gene expression — collagen, elastin, glycosaminoglycan synthesis — alongside fibroblast proliferation and induction of antioxidant genes. The authors note that biological activity in most preclinical models is attributed to the copper-bound complex rather than the free peptide alone, and discuss the equilibrium between the two forms in biological media.
Researchers reviewed what is known about GHK in skin biology. GHK was discovered in human blood in 1973, and levels drop with age. The peptide on its own binds tightly to copper ions, and in most lab studies it is actually the copper-bound form (GHK-Cu) that does the work — switching on genes that build collagen and elastin, waking up the cells that produce these proteins, and turning on the cell's antioxidant defenses. The review explains that plain GHK and GHK-Cu exist in equilibrium in biological fluids depending on how much copper is present.
